Search Results - "Law, V. S"

Conversion of thrombin into an anticoagulant by protein engineering by Gibbs, C. S, Coutré, S. E, Tsiang, M, Li, W-X, Jain, A. K, Dunn, K. E, Law, V. S, Mao, C. T, Matsumura, S. Y, Mejza, S. Y, Paborsky, L. R, Leung, L. L. K

“…At sites of vascular injury, thrombin interacts with multiple procoagulant substrates, to mediate both fibrin clotting and platelet aggregation. But upon…”
Get full text

In Vitro and in Vivo Activities of Oligodeoxynucleotide-Based Thrombin Inhibitors Containing Neutral Formacetal Linkages by He, Gong-Xin, Williams, John P, Postich, Michael J, Swaminathan, S, Shea, Regan G, Terhorst, Terry, Law, Veronica S, Mao, Cheri T, Sueoka, Cathy, Coutré, Steven, Bischofberger, Norbert

“…A series of 15-mer oligodeoxynucleotide analogues were synthesized, and their thrombin inhibitory activities in vitro and in vivo were evaluated. These…”
Get full text

Pilot study of the efficacy of a thrombin inhibitor for use during cardiopulmonary bypass by DeAnda, Abe, Coutre, Steven E., Moon, Marc R., Vial, Conrad M., Griffin, Linda C., Law, Veronica S., Komeda, Masashi, Leung, Lawrence L.K., Miller, D.Craig

“…Heparin is normally used for anticoagulation during cardiopulmonary bypass (CPB), but its use is contraindicated in patients with a history of heparin-induced…”
Get full text

A metagenomic study of bacterial communities associated with the saxitoxin producing dinoflagellate, Pyrodinium bahamense var. compressum by Law, S. V., Rodrigues, K. F., Jani, J., Anton, A., Chin, G. J. W. L.

Get full text

N2- and C8-Substituted Oligodeoxynucleotides with Enhanced Thrombin Inhibitory Activity in Vitro and in Vivo by He, Gong-Xin, Krawczyk, Steven H, Swaminathan, S, Shea, Regan G, Dougherty, Joseph P, Terhorst, Terry, Law, Veronica S, Griffin, Linda C, Coutré, Steven, Bischofberger, Norbert

“…2‘-Deoxyguanosine (G) analogues carrying various hydrophobic substituents in the N2 and C8 positions were synthesized and introduced through solid-phase…”
Get full text

A peptide derived from a tissue factor loop region functions as a tissue factor-factor VIIa antagonist by Paborsky, Lisa R, Law, Veronica S, Mao, Cheri T, Leung, Lawrence L. K, Gibbs, Craig S

“…Tissue factor (TF) is a transmembrane protein that functions in the initiation of blood coagulation in vivo. At sites of vascular injury, TF serves as a…”
Get full text

N super(2) and C super(8)-Substituted Oligodeoxynucleotides with Enhanced Thrombin Inhibitory Activity in Vitro and in Vivo by He, Gong-Xin, Krawczyk, SH, Swaminathan, S, Shea, R G, Dougherty, J P, Terhorst, T, Law, V S, Griffin, L C, Coutre, S, Bischofberger, N

“…2'-Deoxyguanosine (G) analogues carrying various hydrophobic substituents in the N super(2) and C super(8) positions were synthesized and introduced through…”
Get full text

N 2 - and C 8 -Substituted Oligodeoxynucleotides with Enhanced Thrombin Inhibitory Activity in Vitro and in Vivo by He, Gong-Xin, Krawczyk, Steven H., Swaminathan, S., Shea, Regan G., Dougherty, Joseph P., Terhorst, Terry, Law, Veronica S., Griffin, Linda C., Coutré, Steven, Bischofberger, Norbert

Get full text

Pilot study of the efficacy of a thrombin inhibitor for use during cardipulmonary bypass. Discussion by DEANDA, A. JR, COUTRE, S. E, TURLEY, K, MOON, M. R, VIAL, C. M, GRIFFIN, L. C, LAW, V. S, KOMEDA, M, LEUNG, L. L. K, MILLER, D. C, LUPINETTI, F. M

Get full text